Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America. The company was founded in 2008 and is based in Luxembourg.

Moolec Science SA

WARWICK, GB / ACCESS NEWSWIRE / MAY 14, 2026 / MOOLEC SCIENCE LIMITED, A WHOLLY OWNED SUBSIDIARY OF MOOLEC SCIENCE SA (NASDAQ:MLEC) ("THE COMPANY"; "MOOLEC"), AN INNOVATION-DRIVEN COMPANY ENGINEERING PLANTS AND MICROBES TO UNLOCK SCALABLE PROTEIN SOLUTIONS FOR THE GLOBAL FOOD INDUSTRY, TODAY ANNOUNCED THE SUCCESSFUL COMPLETION OF THE 2026 COMMERCIAL PLANTING CAMPAIGN FOR ITS GLASO1 SAFFLOWER PROGRAM FOCUSED ON THE PRODUCTION OF HIGH-GLA ("GAMMA-LINOLENIC ACID") SPECIALTY OILS FOR INDUSTRIAL AND ADVANCED INGREDIENT APPLICATIONS. "TODAY REPRESENTS A DEFINING MOMENT FOR MOOLEC.

MOOLEC SCIENCE SUCCESSFULLY COMPLETES 2026 GLASO COMMERCIAL PLANTING CAMPAIGN IN THE UNITED STATES

GEORGE TOWN, CAYMAN ISLANDS / ACCESS NEWSWIRE / MAY 13, 2026 / AS PREVIOUSLY REPORTED ON JANUARY 29, 2026, MOOLEC SCIENCE SA ("MOOLEC" AND/OR THE "COMPANY"), RECEIVED WRITTEN NOTICE FROM THE NASDAQ HEARINGS PANEL (THE "PANEL") INFORMING THE COMPANY THAT THE PANEL HAD GRANTED THE COMPANY'S REQUEST FOR AN EXTENSION TO REGAIN COMPLIANCE WITH THE CONTINUED LISTING REQUIREMENTS OF THE NASDAQ STOCK MARKET LLC, SPECIFICALLY WITH RESPECT TO THE MINIMUM STOCKHOLDERS' EQUITY REQUIREMENT. THE COMPANY ANNOUNCED TODAY THAT IT HAS SUBMITTED INFORMATION REQUIRED TO DEMONSTRATE COMPLIANCE WITH THE NASDAQ CAPITAL MARKET'S STOCKHOLDERS' EQUITY REQUIREMENT WITHIN THE REMEDIATION PERIOD GRANTED BY THE PANEL.

MOOLEC SCIENCE SA REGAINS COMPLIANCE WITH ALL NASDAQ CAPITAL MARKET CONTINUED LISTING REQUIREMENTS WITHIN PANEL REMEDIATION PERIOD

WARWICK, UK / ACCESS NEWSWIRE / APRIL 29, 2026 / MOOLEC SCIENCE LIMITED, A WHOLLY-OWNED SUBSIDIARY OF MOOLEC SCIENCE SA (NASDAQ:MLEC) ("THE COMPANY"; "MOOLEC"), AN INNOVATION-DRIVEN COMPANY ENGINEERING PLANTS AND MICROBES TO UNLOCK SCALABLE PROTEIN SOLUTIONS FOR THE GLOBAL FOOD INDUSTRY, TODAY ANNOUNCED THE SUCCESSFUL COMPLETION OF THE FIRST PHASE OF INDUSTRIALIZATION OF ITS GLASO1 SAFFLOWER PLATFORM, FOLLOWING A 2025 CAMPAIGN THAT MATERIALLY EXCEEDED ALL INTERNAL FORECASTS. BUILDING ON PREVIOUSLY REPORTED RESULTS CONFIRMING APPROXIMATELY 45% GLA ("GAMMA-LINOLENIC ACID") CONCENTRATION AT COMMERCIAL SCALE, THE COMPANY HAS NOW VALIDATED NOT ONLY AGRONOMIC AND PROCESSING PERFORMANCE, BUT ALSO THE INDUSTRIAL-SCALE HANDLING AND AVAILABILITY OF HIGH-PURITY GLA OUTPUT, MARKING A CRITICAL STEP TOWARD FULL COMMERCIAL DEPLOYMENT.

MOOLEC SCIENCE CONFIRMS COMPLETION OF FIRST PHASE OF GLASO INDUSTRIALIZATION FOLLOWING RECORD 2025 CAMPAIGN; ADVANCES 2026 SOWING AND EXPANDS INTO ENERGY APPLICATIONS

WARWICK, GB / ACCESS NEWSWIRE / APRIL 7, 2026 / MOOLEC SCIENCE LIMITED, A WHOLLY OWNED SUBSIDIARY OF MOOLEC SCIENCE SA (NASDAQ:MLEC) ("THE COMPANY"; "MOOLEC"), AN INNOVATION-DRIVEN COMPANY ENGINEERING PLANTS AND MICROBES TO UNLOCK SCALABLE PROTEIN SOLUTIONS FOR THE GLOBAL FOOD INDUSTRY, TODAY ANNOUNCED A SIGNIFICANT SCIENTIFIC BREAKTHROUGH IN THE PRODUCTION OF ANIMAL PROTEINS IN PLANTS. THROUGH A SPONSORED RESEARCH PROJECT WITH ONE OF THE MOST PRESTIGIOUS ACADEMIC INSTITUTIONS IN THE UNITED STATES OF AMERICA, MOOLEC HAS SUCCESSFULLY DEMONSTRATED THE STABLE EXPRESSION OF BOVINE MYOGLOBIN, A HEME-CONTAINING PROTEIN, WITHIN THE SEEDS OF THE COMMON PEA (PISUM SATIVUM).

MOOLEC SCIENCE ANNOUNCES BREAKTHROUGH IN MOLECULAR FARMING WITH SUCCESSFUL EXPRESSION OF BOVINE MYOGLOBIN IN PEA SEEDS

WARWICK, UK / ACCESS NEWSWIRE / FEBRUARY 13, 2026 / MOOLEC SCIENCE LIMITED, A WHOLLY-OWNED SUBSIDIARY OF MOOLEC SCIENCE SA (NASDAQ:MLEC)("THE COMPANY"; "MOOLEC"), AN INNOVATION-DRIVEN COMPANY ENGINEERING PLANTS AND MICROBES TO UNLOCK SCALABLE PROTEIN SOLUTIONS FOR THE GLOBAL FOOD INDUSTRY, TODAY ANNOUNCED POSITIVE RESULTS FROM THE CRUSHING PROCESS OF ITS U.S. GLASO1 SAFFLOWER PLATFORM, CONFIRMING GAMMA-LINOLENIC ACID ("GLA") CONCENTRATIONS OF APPROXIMATELY 45%. THE RESULTS FOLLOW THE SUCCESSFUL COMPLETION OF MOOLEC'S 2025 U.S. GLASO1 SAFFLOWER CAMPAIGN AND REPRESENT A MAJOR OPERATIONAL MILESTONE, VALIDATING THE COMPANY'S ABILITY TO DELIVER COMMERCIAL-SCALE AGRICULTURAL AND INDUSTRIAL PERFORMANCE THROUGH ITS PLANT-ENGINEERED MOLECULAR FARMING PLATFORM.

MOOLEC SCIENCE ACHIEVES ONE OF THE HIGHEST COMMERCIAL-SCALE GLA CONCENTRATIONS FROM U.S. GLASO1 CRUSHING

GEORGE TOWN, CAYMAN ISLANDS / ACCESS NEWSWIRE / JANUARY 30, 2026 / MOOLEC SCIENCE S.A. ("MOOLEC" OR THE "COMPANY"), A SCIENCE-BASED FOOD INGREDIENT COMPANY FOCUSED ON SCALABLE PROTEIN SOLUTIONS FOR THE GLOBAL MARKET, TODAY ANNOUNCED THAT THE NASDAQ HEARINGS PANEL (THE "PANEL") HAS GRANTED THE COMPANY'S REQUEST FOR CONTINUED LISTING ON THE NASDAQ STOCK MARKET, SUBJECT TO CERTAIN CONDITIONS.

MOOLEC SCIENCE GRANTED CONTINUED LISTING ON NASDAQ SUBJECT TO HEARINGS PANEL CONDITIONS

GEORGE TOWN, CAYMAN ISLANDS / ACCESS NEWSWIRE / JANUARY 23, 2026 / MOOLEC SCIENCE S.A. ("MOOLEC" OR THE "COMPANY") TODAY ANNOUNCED THAT NASDAQ STAFF HAS ISSUED A MEMORANDUM TO THE NASDAQ HEARINGS PANEL (THE "PANEL") CONCLUDING THAT THERE IS SUFFICIENT BASIS TO GRANT MOOLEC AN EXCEPTION THROUGH JUNE 29, 2026 TO DEMONSTRATE COMPLIANCE WITH THE STOCKHOLDERS' EQUITY REQUIREMENT SET FORTH IN NASDAQ LISTING RULE 5550(B)(1) (THE "STOCKHOLDERS' EQUITY REQUIREMENT"), SUBJECT TO CERTAIN DISCLOSURE CONDITIONS.

MOOLEC SCIENCE S.A. RECEIVES NASDAQ STAFF MEMO SUPPORTING PANEL EXCEPTION THROUGH JUNE 29, 2026 TO REGAIN COMPLIANCE WITH STOCKHOLDERS' EQUITY REQUIREMENT

GEORGE TOWN, CAYMAN ISLANDS / ACCESS NEWSWIRE / JANUARY 22, 2026 / MOOLEC SCIENCE S.A. ("MOOLEC" OR THE "COMPANY") TODAY ANNOUNCED THAT IT HAS RECEIVED A DECISION FROM THE NASDAQ HEARINGS PANEL (THE "PANEL") GRANTING THE COMPANY AN EXCEPTION THROUGH JUNE 29, 2026 TO DEMONSTRATE COMPLIANCE WITH THE STOCKHOLDERS' EQUITY REQUIREMENT SET FORTH IN NASDAQ LISTING RULE 5550(B)(1) (THE "STOCKHOLDERS' EQUITY REQUIREMENT"), SUBJECT TO CERTAIN DISCLOSURE CONDITIONS.

MOOLEC SCIENCE S.A. RECEIVES NASDAQ PANEL EXCEPTION THROUGH JUNE 29, 2026 TO REGAIN COMPLIANCE WITH STOCKHOLDERS' EQUITY REQUIREMENT

GEORGE TOWN, CAYMAN ISLANDS / ACCESS NEWSWIRE / JANUARY 5, 2026 / MOOLEC SCIENCE SA ("MOOLEC" OR THE "COMPANY") TODAY ANNOUNCED THAT, IN ACCORDANCE WITH THE RESOLUTIONS PASSED AT THE EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS HELD ON DECEMBER 16, 2025, AND THE RESOLUTIONS ADOPTED BY THE COMPANY'S BOARD OF DIRECTORS ON DECEMBER 19, 2025, THE COMPANY HAS CONSUMMATED, EFFECTIVE AS OF JANUARY 5, 2026, THE PREVIOUSLY ANNOUNCED SHARE CONSOLIDATION AT A RATIO OF 15-FOR-1, SO THAT ALL SHAREHOLDERS HOLDING EVERY 15 ORDINARY SHARES OF PAR VALUE OF US$0.10 EACH WILL HOLD 1 ORDINARY SHARE OF PAR VALUE US$1.50 EACH (THE "SHARE CONSOLIDATION"). AS A RESULT, EVERY 15 ORDINARY SHARES OF THE COMPANY, PAR VALUE US$0.10 PER SHARE EACH (WITH PAR VALUE TO BE AMENDED FROM TIME TO TIME, THE "SHARES"), ISSUED AND OUTSTANDING IMMEDIATELY PRIOR TO THE SHARE CONSOLIDATION, WERE AUTOMATICALLY CONSOLIDATED INTO 1 VALIDLY ISSUED, PAR VALUE US$1.50 EACH, FULLY PAID AND NON-ASSESSABLE SHARE, WITHOUT ANY ACTION REQUIRED BY ANY SHAREHOLDER.

MOOLEC SCIENCE ANNOUNCES EFFECTIVENESS OF SHARE CONSOLIDATION

GEORGE TOWN, CAYMAN ISLANDS / ACCESS NEWSWIRE / DECEMBER 31, 2025 / MOOLEC SCIENCE SA ("MOOLEC" OR THE "COMPANY") RECEIVED AN ADDITIONAL DETERMINATION LETTER (THE "LETTER") FROM THE LISTING QUALIFICATIONS DEPARTMENT OF THE NASDAQ STOCK MARKET LLC ("NASDAQ") INDICATING THAT THE COMPANY DOES NOT CURRENTLY MEET THE MINIMUM STOCKHOLDERS' EQUITY REQUIREMENT OF $2.5 MILLION UNDER NASDAQ LISTING RULE 5550(B)(1). AS PREVIOUSLY DISCLOSED IN THE COMPANY'S FORM 20-F FOR THE YEAR ENDED JUNE 30, 2025, MANAGEMENT EXPECTS TO REGAIN COMPLIANCE WITH THE NASDAQ CONTINUED LISTING STANDARDS THROUGH THE RECOGNITION OF AN ESTIMATED GAIN OF APPROXIMATELY $105.8 MILLION RELATED TO THE DERECOGNITION OF CERTAIN SUBSIDIARIES FOLLOWING THEIR BANKRUPTCY PROCEEDINGS.

Moolec Science SA

MLEC

Price

Financial Reports

No items found.

Press Releases

Moolec Science SA

MLEC.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financial Reports

No items found.

Press Releases

MLEC